- Home
- KPLT vs DYAI Comparison
KPLT vs DYAI Comparison
Compare KPLT & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KPLT
- DYAI
- Stock Information
- Founded
- KPLT 2012
- DYAI 1979
- Country
- KPLT United States
- DYAI United States
- Employees
- KPLT N/A
- DYAI N/A
- Industry
- KPLT Diversified Commercial Services
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KPLT Consumer Discretionary
- DYAI Health Care
- Exchange
- KPLT Nasdaq
- DYAI Nasdaq
- Market Cap
- KPLT 35.5M
- DYAI 31.5M
- IPO Year
- KPLT N/A
- DYAI 2004
- Fundamental
- Price
- KPLT $6.61
- DYAI $1.93
- Analyst Decision
- KPLT Hold
- DYAI Strong Buy
- Analyst Count
- KPLT 2
- DYAI 1
- Target Price
- KPLT $12.00
- DYAI $6.00
- AVG Volume (30 Days)
- KPLT 45.1K
- DYAI 54.2K
- Earning Date
- KPLT 11-06-2024
- DYAI 11-12-2024
- Dividend Yield
- KPLT N/A
- DYAI N/A
- EPS Growth
- KPLT N/A
- DYAI N/A
- EPS
- KPLT N/A
- DYAI N/A
- Revenue
- KPLT $241,789,000.00
- DYAI $3,364,548.00
- Revenue This Year
- KPLT $14.79
- DYAI $2.04
- Revenue Next Year
- KPLT $12.23
- DYAI $110.34
- P/E Ratio
- KPLT N/A
- DYAI N/A
- Revenue Growth
- KPLT 14.99
- DYAI 13.82
- 52 Week Low
- KPLT $5.79
- DYAI $0.93
- 52 Week High
- KPLT $23.54
- DYAI $2.67
- Technical
- Relative Strength Index (RSI)
- KPLT 36.79
- DYAI 85.65
- Support Level
- KPLT $5.79
- DYAI $1.08
- Resistance Level
- KPLT $7.61
- DYAI $1.80
- Average True Range (ATR)
- KPLT 0.61
- DYAI 0.18
- MACD
- KPLT 0.00
- DYAI 0.08
- Stochastic Oscillator
- KPLT 25.55
- DYAI 89.21
About KPLT Katapult Holdings Inc.
Katapult Holdings Inc. is a technology-driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchase of everyday durable goods for underserved U.S. non-prime consumers. It is an e-commerce-focused FinTech company offering a lease-purchase solution to consumers and enabling essential transactions at the merchant point of sale. Katapult is associated with hundreds of retailers across the United States.
About DYAI Dyadic International Inc.
Dyadic International Inc is a world-wide biotechnology platform company. The company has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins, and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.